ILD Center Media

A new review aims to help clinicians better recognize subtle signs of pneumonitis before they escalate.

For Erica Herzog, MD, PhD, being a mentor is a privilege that is immensely fulfilling. This summer, two of Herzog’s mentees met career benchmarks, and both credit Herzog and her guidance for getting them there.

When Naftali Kaminski, MD, was recruited to Yale in 2013 as section chief of Pulmonary, Critical Care and Sleep Medicine (Yale-PCCSM) he planned to lead it for 10 years. Now, coming up on his thirteenth year, he is stepping down at the end of June 2026.

Each year, the American College of Chest Physicians (CHEST) honors the clinicians, researchers, and educators shaping the future of chest medicine. Among this year’s distinguished honorees are several faculty members from the Section of Pulmonary, Critical Care, and Sleep Medicine at Yale School of Medicine (Yale-PCCSM), recognized for their leadership, innovation, and dedication to the field.

A new paper from Yale School of Medicine researchers suggests that variants of uncertain significance—DNA changes that scientists can detect but, at this time, lack enough evidence to classify as harmful or harmless—may offer important clinical insights that deserve closer attention.

Pulmonary fibrosis is a condition that causes scarring of the lungs. It is often accompanied by shortness of breath, cough, rapid loss of lung function, and respiratory failure.

A new collaborative program, the Ugandan Registry of RMDs in HIV (GEMINI), aims to improve the study of HIV and rheumatic and musculoskeletal diseases (RMDs) in Uganda.

Yale researchers developed an AI model that illuminates critical details about—and possible treatments for—idiopathic pulmonary fibrosis. It could do so for many other diseases.

Wonnie Ryu, MD, MPH, is the recipient of the American Thoracic Society (ATS) Assembly on Respiratory Cell and Molecular Biology Rising Star Award.